Heparin-associated thrombocytopenia and thrombosis

The Journal of Laboratory and Clinical Medicine

Volumn 111, Issue 6, 1988, Pages 600-605

  Bell, William R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

BLEEDING; BLOOD TRANSFUSION; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; REVIEW; THROMBOCYTOPENIA; THROMBOSIS;

DEXTRANS; EXTRACORPOREAL CIRCULATION; HEPARIN; HUMAN; PLATELET COUNT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOCYTOPENIA; THROMBOSIS; TIME FACTORS; WARFARIN;

EID: 0023919706     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Klinische and gerinnungaphysiologische untersuchungen mit, einem neuen Heparindepotpraparat
2. Thrombocytopenic and related physiological effects of heparin and heparinoids: a macromolecular-induced syndrome
3. Chemistry and pharmacology of heparin
4. Complications of heparin therapy
5. Disseminated intravascular coagulopathy during heparin therapy
6. Thrombocytopenia occurring during the administration of heparin: a prospective study in 52 patients
7. Thrombocytopenia occurring during heparin therapy
8. Heparin-induced coagulopathy
9. Arterial Embolism Occurring During Systemic Heparin Therapy
10. Heparin-Induced Immune Thrombocytopenia
11. Heparin induced thrombocytopenia: eight cases with thrombosic-hemorrhagic complications
12. Thrombocytopenia associated with antiheparin antibody
13. Heparin-related immune thrombocytopenia. Studies of antibody-heparin specificity
14. Heparin immune thrombocytopenia: evidence for a heparin-platelet complex as the antigenic determinant
15. Heparin induced thrombocytopenia: life and limb threatening complication of heparin therapy
16. White clot syndrome
17. Heparin-induced thrombocytopenia, thrombosis, hemorrhage
18. Thrombotic complications of heparin therapy
19. Heparin-induced thrombocytopenia and recurrent thromboembolism
20. Heparin-induced thrombocytopenia, thrombosis and hemorrhage
21. Heparin associated thrombocytopenia. A prospective evaluation of 211 patients
22. Heparin-associated thrombocytopenia
23. Heparin-associated thrombocytopenia: antibody binding specificity to platelet antigens
24. Heparin-induced thrombocytopenia: a prospective study of 142 patients
25. Venous gangrene associated with heparin-induced thrombocytopenia
26. Heparin associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution
27. Heparin-induced thrombocytopenia and recurrent thrombosis in pregnancy
28. Different platelet specificities of heparindependent platelet aggregating factors in heparin-associated immune thrombocytopenia
29. Heparin-induced thrombocytopenia: further studies of the effects of heparin-dependent antibodies on platelets
30. Immune endothelial-cell injury in heparin-associated thrombocytopenia
31. White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases
32. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia
33. An enzyme-linked immunosorbent assay for evaluation of thrombocytopenia induced by heparin
34. A diagnostic test for heparin-induced thrombocytopenia
35. Thrombocytopenia induced by low-dose subcutaneous heparin
36. Heparin-induced thrombocytopenia/thrombosis: clinical manifestation and insights
37. Heparin associated thrombocytopenia: comparison of three heparin preparations
38. Heparin flushes and thrombocytopenia
39. Heparin-associated thrombocytopenia in the neurosurgical patient
40. 2: effects upon platelets
41. 1, antiaggregating effect in human platelets
42. Heparin-associated thrombocytopenia
43. In vitro studies of heparin-associated thrombocytopenia
44. The clotting behavior of human “platelet-free” plasma: evidence for the existence of a “plasma thromboplastin”
45. The heparin-induced thrombocytopenia syndrome: an update.
46. Antiheparin antibodies: their preparation and use in a heparin immunoassay
47. Therapeutic defibrination in the treatment of thrombosic disease
48. The effect of arvin on blood coagulation factors
49. Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery
50. Thrombolysis in heparin-induced thrombocytopenia with thrombosis
51. Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia